<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">NS</journal-id><journal-title-group><journal-title>Nursing Science</journal-title></journal-title-group><issn pub-type="epub">2168-5657</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/NS.2019.83044</article-id><article-id pub-id-type="publisher-id">NS-30540</article-id><article-categories><subj-group subj-group-type="heading"><subject>NS20190300000_12747238.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  2型糖尿病大血管病变患者颈动脉内中膜厚度与血清CRP及Cys-C水平的相关性研究
  The Relevant Research between Carotid Intima-Media Thickness in Patients with Type 2 Diabetic Macroangiopathy, Serum CRP, and Level of Cys-C
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>蕊</given-names></name><xref ref-type="aff" rid="aff1"><sub>1</sub></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>承德医学院附属医院，河北 承德</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>05</month><year>2019</year></pub-date><volume>08</volume><issue>03</issue><fpage>232</fpage><lpage>237</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   目的：探讨2型糖尿病(T2DM)大血管病变患者颈动脉内中膜厚度(CIMT)与血清C反应蛋白(CRP)、胱抑素C (Cys-C)水平的相关性。方法：选择本院2016年3月~2018年3月收治的T2DM大血管病变患者52例、单纯T2DM患者60例及同期体检正常人员50例，分别纳入病变组、T2DM组、对照组。测定比较各组血糖、血脂、CIMT、血清CRP、Cys-C水平，CIMT与血清CRP、Cys-C之间行Pearson相关性分析，大血管病变的危险因素行Logistic回归分析。结果：病变组空腹血糖(FPG)、餐后2小时血糖(2 hPG)、糖化血红蛋白(HbAlc)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、CIMT、CRP及Cys-C水平水平均显著大于T2DM组、对照组，且T2DM组均显著大于对照组，差异有统计学意义(P &lt; 0.05)；CIMT与血清CRP、Cys-C水平均正相关(P &lt; 0.01)；Logistic多元逐步回归分析T2DM患者大血管病变的独立危险因素包括高HbAlc、LDL-C、CRP及Cys-C水平(P &lt; 0.05)。结论：T2DM大血管病变患者CIMT与血清CRP、Cys-C正相关。 Objective: To investigate the relationship between carotid intima-media thickness (CIMT) in pa-tients with type 2 diabetes mellitus (T2DM), serum C-reactive protein (CRP) and level of cystatin C (Cys-C). Methods: 52 patients with T2DM macroangiopathy, 60 patients with T2DM alone, 50 pa-tients with normal physical examination from March 2016 to March 2018 were selected; they were divided into the lesion group, T2DM group and control group respectively. Blood glucose, blood lipids, CIMT, serum CRP, the level of Cys-C, the correlation analysis between CIMT and serum CRP and Cys-C and logistic regression analysis for the risk factors of macrovascular disease were measured. Results: Fasting blood glucose (FPG), 2 hours postprandial blood glucose (2 hPG), gly-cosylated hemoglobin (HbAlc), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), CIMT, CRP and the level of Cys-C in the lesion group were significantly greater than those in the T2DM group and the control group (P &lt; 0.05); CIMT was positively correlated with serum CRP and Cys-C levels (P &lt; 0.01); independent risk factors for macrovascular disease in patients with T2DM included high HbAlc, LDL-C, CRP, and level of Cys-C by logistic multiple stepwise regression analysis (P &lt; 0.05). Conclusion: CIMT in patients with T2DM macrovascular disease is positively correlated with serum CRP and Cys-C.
    
  
 
</p></abstract><kwd-group><kwd>2型糖尿病，大血管病变，颈动脉内中膜厚度，C反应蛋白，胱抑素C, Type 2 Diabetes</kwd><kwd> Macrovascular Disease</kwd><kwd> Carotid Intima-Media Thickness</kwd><kwd> C-Reactive Protein</kwd><kwd> Cystatin C</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>2型糖尿病大血管病变患者颈动脉内中膜厚度与血清CRP及Cys-C水平的相关性研究<sup> </sup></title><p>张蕊</p><p>承德医学院附属医院，河北 承德</p><p><img src="//html.hanspub.org/file/10-2250484x1_hanspub.png" /></p><p>收稿日期：2019年5月7日；录用日期：2019年5月21日；发布日期：2019年5月30日</p><disp-formula id="hanspub.30540-formula13"><graphic xlink:href="//html.hanspub.org/file/10-2250484x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：探讨2型糖尿病(T2DM)大血管病变患者颈动脉内中膜厚度(CIMT)与血清C反应蛋白(CRP)、胱抑素C (Cys-C)水平的相关性。方法：选择本院2016年3月~2018年3月收治的T2DM大血管病变患者52例、单纯T2DM患者60例及同期体检正常人员50例，分别纳入病变组、T2DM组、对照组。测定比较各组血糖、血脂、CIMT、血清CRP、Cys-C水平，CIMT与血清CRP、Cys-C之间行Pearson相关性分析，大血管病变的危险因素行Logistic回归分析。结果：病变组空腹血糖(FPG)、餐后2小时血糖(2 hPG)、糖化血红蛋白(HbAlc)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、CIMT、CRP及Cys-C水平水平均显著大于T2DM组、对照组，且T2DM组均显著大于对照组，差异有统计学意义(P &lt; 0.05)；CIMT与血清CRP、Cys-C水平均正相关(P &lt; 0.01)；Logistic多元逐步回归分析T2DM患者大血管病变的独立危险因素包括高HbAlc、LDL-C、CRP及Cys-C水平(P &lt; 0.05)。结论：T2DM大血管病变患者CIMT与血清CRP、Cys-C正相关。</p><p>关键词 :2型糖尿病，大血管病变，颈动脉内中膜厚度，C反应蛋白，胱抑素C</p><disp-formula id="hanspub.30540-formula14"><graphic xlink:href="//html.hanspub.org/file/10-2250484x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2019 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/10-2250484x7_hanspub.png" /> <img src="//html.hanspub.org/file/10-2250484x8_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>2型糖尿病(T2DM)大血管病变与动脉粥样硬化密切相关，是导致患者死亡的重要原因 [<xref ref-type="bibr" rid="hanspub.30540-ref1">1</xref>] 。颈动脉内膜中层厚度(CIMT)是评价早期动脉粥样硬化的重要指标，有报道发现CIMT增厚可预测T2DM患者心血管事件发生 [<xref ref-type="bibr" rid="hanspub.30540-ref2">2</xref>] 。炎症被公认为是T2DM、大血管病变发病机制之一，C反应蛋白(CRP)为炎症标志物，被发现参与动脉粥样硬化发生、进展过程 [<xref ref-type="bibr" rid="hanspub.30540-ref3">3</xref>] 。胱抑素C (Cys-C)临床上多用于早期肾功能损害评价，近年来有研究发现血清Cys-C水平与冠心病等心血管疾病密切相关 [<xref ref-type="bibr" rid="hanspub.30540-ref4">4</xref>] ，但关于Cys-C与T2DM大血管病变的相关性报道较少。本研究主要分析T2DM大血管病变患者CIMT与血清CRP、Cys-C水平的相关性。报告如下。</p></sec><sec id="s4"><title>2. 资料与方法</title><sec id="s4_1"><title>2.1. 一般资料</title><p>抽取本院2016年3月~2018年3月收治的T2DM患者112例，其中大血管病变52例纳入病变组，单纯T2DM患者60例纳入T2DM组。选择同期健康体检50例正常人员为对照组。对比三组基线资料差异无统计学意义(P &gt; 0.05)，见表1。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparison of three groups of baseline dat</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >组别</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >男/女</th><th align="center" valign="middle" >年龄(岁)</th><th align="center" valign="middle" >糖尿病病程(年)</th><th align="center" valign="middle" >体重指数(kg/m<sup>2</sup>)</th></tr></thead><tr><td align="center" valign="middle" >病变组</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >30/22</td><td align="center" valign="middle" >57.63 &#177; 7.20</td><td align="center" valign="middle" >4.84 &#177; 0.59</td><td align="center" valign="middle" >24.40 &#177; 1.68</td></tr><tr><td align="center" valign="middle" >T2DM组</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >33/27</td><td align="center" valign="middle" >58.00 &#177; 6.96</td><td align="center" valign="middle" >5.01 &#177; 0.61</td><td align="center" valign="middle" >23.96 &#177; 2.02</td></tr><tr><td align="center" valign="middle" >对照组</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >27/23</td><td align="center" valign="middle" >56.85 &#177; 6.64</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >24.00 &#177; 1.85</td></tr><tr><td align="center" valign="middle" >F或t</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.153</td><td align="center" valign="middle" >0.383</td><td align="center" valign="middle" >1.493</td><td align="center" valign="middle" >0.910</td></tr><tr><td align="center" valign="middle" >P</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.926</td><td align="center" valign="middle" >0.683</td><td align="center" valign="middle" >0.138</td><td align="center" valign="middle" >0.404</td></tr></tbody></table></table-wrap><p>表1. 三组基线资料比较</p></sec><sec id="s4_2"><title>2.2. 纳入及排除标准</title><p>纳入标准：1) 符合T2DM诊断标准 [<xref ref-type="bibr" rid="hanspub.30540-ref5">5</xref>] ；2) 大血管病变指的是冠心病、脑血管疾病或外周血管病中的1种或以上，经冠脉造影或外周血管彩色多普勒超声检查等确诊；3) 无糖尿病急性并发症；4) 相关资料完整。排除标准：1) 肝、肾、心、肺异常；2) 妊娠、母乳喂养者；3) 糖尿病肾病等微血管病变；4) 合并恶性肿瘤、慢性肝病等全身代谢异常疾病；5) 近期有激素类药物使用史；6) 自身免疫相关疾病。</p></sec><sec id="s4_3"><title>2.3. 方法</title><p>1) 血清指标检测 病变组、T2DM组患者入院次日清晨空腹采集外周静脉血，对照组人员则空腹12小时后清晨采集外周静脉血，以3000转/分钟离心10分钟，血清分离后低温保存。通过乳胶增强免疫比浊法测定各组对象血清CRP水平，试剂盒购自上海奥普生物医药有限公司；通过乳胶免疫比浊法测定Cys-C水平，试剂盒购自天津中成佳益生物科技有限公司。另外，对各组对象空腹血糖(FPG)、餐后2小时血糖(2 hPG)、糖化血红蛋白(HbAlc)、总胆固醇(TC)、甘油三酯(TG)、高密度值蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)水平测定，仪器为贝克曼5800生化仪与BIO-RAD D-10糖化血红蛋白分析仪。</p><p>2) CIMT检测 仪器为日本HITACHI HI VISION Preirus彩色多普勒超声诊断仪。仰卧位，肩垫高，检查侧颈部显露，头偏一侧，先对颈总动脉探查，随后顺着走向往头移动，前、侧、后不同方向对颈总动脉横轴、纵轴二维图像观察。颈动脉窦下1 cm左右颈总动脉后壁内膜–管腔分界线与中外膜分界线之间的距离即IMT。多次测量，取均值，即CIMT。CIMT 0.9 mm或以上判断为增厚，0.9 mm以下判断为正常 [<xref ref-type="bibr" rid="hanspub.30540-ref6">6</xref>] 。</p></sec><sec id="s4_4"><title>2.4. 统计学处理</title><p>SPSS17.0软件处理数据。计量资料以 x &#175; &#177; s 表示，多组间行单因素方差分析，两两行LSD-t检验；Pearson相关性分析CIMT与CRP、CysC的关系；Logistic回归分析大血管病变的相关因素，P &lt; 0.05为差异有统计学意义。</p></sec></sec><sec id="s5"><title>3. 结果</title><sec id="s5_1"><title>3.1. 血糖、血脂指标</title><p>病变组FPG、2 hPG、HbAlc、TC、LDL-C水平均明显高于T2DM组、对照组，差异有统计学意义(P &lt; 0.05)；T2DM组患者FPG、2 hPG、HbAlc、TC、TG、LDL-C水平均明显高于对照组(P &lt; 0.05)；病变组与T2DM组TG、HDL-C水平比较差异均无统计学意义(P &gt; 0.05)。见表2。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of blood glucose and blood lipids in three groups of subjects ( x &#175; &#177; s </title></caption><table><tbody><thead><tr><th align="center" valign="middle" >组别</th><th align="center" valign="middle" >n</th><th align="center" valign="middle"  colspan="3"  >血糖指标</th><th align="center" valign="middle"  colspan="4"  >血脂指标</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >FPG (mmol/L)</td><td align="center" valign="middle" >2 hPG (mmol/L)</td><td align="center" valign="middle" >HbAlc (%)</td><td align="center" valign="middle" >TC (mmol/L)</td><td align="center" valign="middle" >TG (mmol/L)</td><td align="center" valign="middle" >HDL-C (mmol/L)</td><td align="center" valign="middle" >LDL-C (mmol/L)</td></tr><tr><td align="center" valign="middle" >病变组</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >11.28 &#177; 1.53<sup>*#</sup></td><td align="center" valign="middle" >14.19 &#177; 1.94<sup>*#</sup></td><td align="center" valign="middle" >8.93 &#177; 1.15<sup>*#</sup></td><td align="center" valign="middle" >5.70 &#177; 0.80<sup>*#</sup></td><td align="center" valign="middle" >1.86 &#177; 0.25<sup>*</sup></td><td align="center" valign="middle" >1.02 &#177; 0.14<sup>*</sup></td><td align="center" valign="middle" >4.15 &#177; 0.53<sup>*#</sup></td></tr><tr><td align="center" valign="middle" >T2DM组</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >9.34 &#177; 1.26<sup>*</sup></td><td align="center" valign="middle" >12.28 &#177; 1.72<sup>*</sup></td><td align="center" valign="middle" >8.52 &#177; 1.16<sup>*</sup></td><td align="center" valign="middle" >5.15 &#177; 0.69<sup>*</sup></td><td align="center" valign="middle" >1.82 &#177; 0.23<sup>*</sup></td><td align="center" valign="middle" >1.07 &#177; 0.15<sup>*</sup></td><td align="center" valign="middle" >3.51 &#177; 0.44<sup>*</sup></td></tr><tr><td align="center" valign="middle" >对照组</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >5.01 &#177; 0.63</td><td align="center" valign="middle" >6.47 &#177; 0.85</td><td align="center" valign="middle" >5.14 &#177; 0.67</td><td align="center" valign="middle" >4.30 &#177; 0.58</td><td align="center" valign="middle" >1.14 &#177; 0.16</td><td align="center" valign="middle" >1.38 &#177; 0.20</td><td align="center" valign="middle" >2.49 &#177; 0.31</td></tr><tr><td align="center" valign="middle" >F</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >359.245</td><td align="center" valign="middle" >326.768</td><td align="center" valign="middle" >209.698</td><td align="center" valign="middle" >52.163</td><td align="center" valign="middle" >177.793</td><td align="center" valign="middle" >72.466</td><td align="center" valign="middle" >186.320</td></tr><tr><td align="center" valign="middle" >P</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr></tbody></table></table-wrap><p>表2. 三组对象血糖、血脂指标比较( x &#175; &#177; s )</p><p>注：与对照组比较，<sup>*</sup>P &lt; 0.05；与T2DM组比较，<sup>#</sup>P &lt; 0.05。</p></sec><sec id="s5_2"><title>3.2. CIMT、血清CRP、Cys-C水平</title><p>病变组CIMT、CRP、Cys-C水平均明显大于T2DM组、对照组，且T2DM组均明显大于对照组，差异有统计学意义(P &lt; 0.05)。见表3。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison of CIMT, serum CRP, and Cys-C levels in three groups of subjects ( x &#175; &#177; s </title></caption><table><tbody><thead><tr><th align="center" valign="middle" >组别</th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >CIMT (mm)</th><th align="center" valign="middle" >CRP (mg/L)</th><th align="center" valign="middle" >Cys-C (mg/L)</th></tr></thead><tr><td align="center" valign="middle" >病变组</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >1.45 &#177; 0.21<sup>*#</sup></td><td align="center" valign="middle" >4.34 &#177; 0.59<sup>*#</sup></td><td align="center" valign="middle" >2.60 &#177; 0.58<sup>*#</sup></td></tr><tr><td align="center" valign="middle" >T2DM组</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >1.05 &#177; 0.23<sup>*</sup></td><td align="center" valign="middle" >2.75 &#177; 0.37<sup>*</sup></td><td align="center" valign="middle" >1.26 &#177; 0.32<sup>*</sup></td></tr><tr><td align="center" valign="middle" >对照组</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >0.67 &#177; 0.10</td><td align="center" valign="middle" >1.23 &#177; 0.16</td><td align="center" valign="middle" >0.85 &#177; 0.14</td></tr><tr><td align="center" valign="middle" >F</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >210.546</td><td align="center" valign="middle" >724.142</td><td align="center" valign="middle" >285.792</td></tr><tr><td align="center" valign="middle" >P</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >&lt;0.001</td></tr></tbody></table></table-wrap><p>表3. 三组对象CIMT、血清CRP、Cys-C水平比较( x &#175; &#177; s )</p><p>注：与对照组比较，<sup>*</sup>P &lt; 0.05；与T2DM组比较，<sup>#</sup>P &lt; 0.05。</p></sec><sec id="s5_3"><title>3.3. 相关性分析</title><p>Pearson相关性分析发现CIMT与血清CRP、Cys-C水平均正相关(r = 0.700、0.742，P &lt; 0.01)。</p></sec><sec id="s5_4"><title>3.4. 大血管病变危险因素分析</title><p>以T2DM患者大血管病变为因变量，以糖尿病病程、HbAlc、TG、TC、LDL-C、HDL-C、CRP、Cys-C为自变量，对大血管病变的危险因素行多元逐步回归分析，显示高HbAlc、LDL-C、CRP、Cys-C水平是大血管病变发生的独立危险因素(P &lt; 0.05)。见表4。</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Logistic regression analysis of T2DM macroangiopath</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >变量</th><th align="center" valign="middle" >回归系数</th><th align="center" valign="middle" >SE</th><th align="center" valign="middle" >Wald值</th><th align="center" valign="middle" >OR值</th><th align="center" valign="middle" >(95% CI)</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >HbAlc</td><td align="center" valign="middle" >3.214</td><td align="center" valign="middle" >1.105</td><td align="center" valign="middle" >8.460</td><td align="center" valign="middle" >24.878</td><td align="center" valign="middle" >2.853~216.979</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >LDL-C</td><td align="center" valign="middle" >1.780</td><td align="center" valign="middle" >0.853</td><td align="center" valign="middle" >4.355</td><td align="center" valign="middle" >5.930</td><td align="center" valign="middle" >1.114~31.560</td><td align="center" valign="middle" >0.037</td></tr><tr><td align="center" valign="middle" >CRP</td><td align="center" valign="middle" >2.547</td><td align="center" valign="middle" >1.005</td><td align="center" valign="middle" >6.423</td><td align="center" valign="middle" >12.769</td><td align="center" valign="middle" >1.781~91.542</td><td align="center" valign="middle" >0.012</td></tr><tr><td align="center" valign="middle" >Cys-C</td><td align="center" valign="middle" >2.200</td><td align="center" valign="middle" >1.007</td><td align="center" valign="middle" >4.773</td><td align="center" valign="middle" >9.025</td><td align="center" valign="middle" >1.254~64.957</td><td align="center" valign="middle" >0.029</td></tr></tbody></table></table-wrap><p>表4. 影响T2DM大血管病变的Logistic回归分析</p></sec></sec><sec id="s6"><title>4. 讨论</title><p>有报道称，T2DM大血管病变相比单纯糖尿病明显增加心血管事件风险(3到4倍)，其致残率、病死率均较高 [<xref ref-type="bibr" rid="hanspub.30540-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.30540-ref8">8</xref>] 。为此早期防治大血管病变，对改善T2DM患者预后至关重要，其中发现大血管病变相关危险因素被认为是预防其病变的关键。</p><p>炎症学说一直是T2DM及其大血管病变研究的重点。CRP产生与肝脏有关，属于急性时相蛋白，为炎症反映常见敏感指标。Karen等 [<xref ref-type="bibr" rid="hanspub.30540-ref9">9</xref>] 研究发现T2DM病人血清CRP水平明显上升。认为CRP水平为糖尿病有效预测因子。杨茜等 [<xref ref-type="bibr" rid="hanspub.30540-ref10">10</xref>] 研究发现，T2DM患者血清超敏CRP水平比正常人员显著高，比大血管病变者显著低。提示血清超敏CRP水平参与T2DM及其大血管病变发生，本研究结果与之相符。认为炎症介导的急性时相反应介导T2DM大血管病变发生，血清CRP水平显著上升。同时本研究发现CIMT与血清CRP显著正相关，与卢薇等 [<xref ref-type="bibr" rid="hanspub.30540-ref11">11</xref>] 结果一致。表明炎症与T2DM大血管病变发生密切相关。这可能与CDP结合脂蛋白将补体系统激活，促使终末复合物大量产生，导致血管内皮损伤，同时T2DM患者血管硬化时，CRP还能对单核细胞、补体激活，促使黏附因子产生，最终损伤内皮细胞功能，引发大血管病变。另外，本研究还行Logistic回归分析，发现CRP是T2DM大血管病变发生的独立危险因素。认为CRP可作为T2DM患者大血管病变发生预测因子。</p><p>Cys-C属于内源性半胱氨酸蛋白酶抑制剂，其产生与有核细胞有关，且炎症、性别、年龄等对其无影响，具有产生率恒定特点，被公认为是肾功能损伤评价敏感指标。近年来有研究发现Cys-C水平上升与动脉粥样硬化、炎症或心血管事件发生有关 [<xref ref-type="bibr" rid="hanspub.30540-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.30540-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.30540-ref14">14</xref>] 。陈广树等 [<xref ref-type="bibr" rid="hanspub.30540-ref15">15</xref>] 研究发现T2DM患者、单纯T2DM患者、健康体检者血清Cys-C水平依次下降，且Cys-C (1.35 mg/L以上)与超氧化物歧化酶(126 U/mL以下)联合诊断T2DM大血管病变的敏感度、特异度分别为85.6%、89.2%。本研究结果显示，T2DM患者血清Cys-C水平均显著高于单纯T2DM患者、健康体检人员，与相关报道结果相符 [<xref ref-type="bibr" rid="hanspub.30540-ref16">16</xref>] 。同时本研究发现CIMT与血清Cys-c水平正相关，与卢薇等结果不一致，而与黄漓莉等 [<xref ref-type="bibr" rid="hanspub.30540-ref17">17</xref>] 结果一致。出现上述差异可能与Cys-C与慢性炎症是否相关有关。Cys-C有抗炎作用，对中性粒细胞迁移有所影响，参与冠心病动脉粥样硬化炎症过程 [<xref ref-type="bibr" rid="hanspub.30540-ref18">18</xref>] 。本研究未对CysC与CRP相关性分析，关于CysC与慢性炎症的明确关系有待日后进一步分析。</p><p>另外，本研究还对T2DM大血管病变发生相关因素行Logistic回归分析。发现HbAlc、LDL-C、CRP、Cys-C是T2DM患者大血管病变发生的独立危险因素。血脂被公认为是颈动脉粥样硬化发生的独立危险因素，而炎症对T2DM、动脉粥样硬化发生、进展有促进作用。认为早期检测T2DM患者CRP、Cys-C、CIMI，对大血管病变有一定的预测价值，可及时发现病变并治疗，以延缓病情，改善患者预后。</p><p>综上，T2DM大血管病变相比单纯T2DM患者血清CRP、Cys-C水平明显上升，其水平与CIMT正相关。CRP、Cys-C是T2DM大血管病变发生的独立危险因素。</p></sec><sec id="s7"><title>文章引用</title><p>张 蕊. 2型糖尿病大血管病变患者颈动脉内中膜厚度与血清CRP及Cys-C水平的相关性研究The Relevant Research between Carotid Intima-Media Thickness in Patients with Type 2 Diabetic Macroangiopathy, Serum CRP, and Level of Cys-C[J]. 护理学, 2019, 08(03): 232-237. https://doi.org/10.12677/NS.2019.83044</p></sec><sec id="s8"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.30540-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">黄伟煌, 张丽菊, 井立鹏, 等. 2型糖尿病大血管病变风险及其交互作用分析[J]. 中华疾病控制杂志, 2015, 19(1): 13-16.</mixed-citation></ref><ref id="hanspub.30540-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Saba, L., Ikeda, N., Deidda, M., et al. (2013) Association of Automated Carotid IMT Measurement and HbA1c in Japa-nese Patients with Coronary Artery Disease. Diabetes Research and Clinical Practice, 100, 348-353.  
&lt;br&gt;https://doi.org/10.1016/j.diabres.2013.03.032</mixed-citation></ref><ref id="hanspub.30540-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">张月华, 周嘉强. 老年2型糖尿病白细胞介素-6、C反应蛋白、血管内皮生长因子与大血管病变的相关性[J]. 中国老年学杂志, 2015(20): 5796-5798.</mixed-citation></ref><ref id="hanspub.30540-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">王俊, 王邦宁, 王安才, 等. 冠心病患者血清胱抑素C水平与冠状动脉病变程度相关性分析[J]. 重庆医学, 2015, 44(4): 475-477, 481.</mixed-citation></ref><ref id="hanspub.30540-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中国糖尿病杂志, 2014, 30(8): 893-942.</mixed-citation></ref><ref id="hanspub.30540-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Crouse, J.R., Harpold, G.H., Kahl, F.R., et al. (1986) Evaluation of a Scoring System for Extracranial Carotid Atherosclerosis Extent with B-Mode Ultrasound. Stoke, 17, 270-275. &lt;br&gt;https://doi.org/10.1161/01.STR.17.2.270</mixed-citation></ref><ref id="hanspub.30540-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hernandez, J.S., Aguilar, S.C., Mehta, R., et al. (2011) Management of Type 2 Diabetes: More Evidence Is Required to Address the Clinical and Contextual Facets. Current Diabetes Reviews, 7, 99-105.  
&lt;br&gt;https://doi.org/10.2174/157339911794940710</mixed-citation></ref><ref id="hanspub.30540-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">韩琼, 严立, 胡锐, 等. 老年糖尿病患者大血管病变发生情况调查及危险因素分析[J]. 中国老年学杂志, 2015, 35(23): 6770-6771.</mixed-citation></ref><ref id="hanspub.30540-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Karen, L.S., Carol, S.J., Kristin, D.R., et al. (2014) Almond Sup-plementation in the Absence of Dietary Advice Significantly Reduces C-Reactive Protein in Subjects with Type 2 Diabetes. Journal of Functional Foods, 10, 252-259.  
&lt;br&gt;https://doi.org/10.1016/j.jff.2014.06.024</mixed-citation></ref><ref id="hanspub.30540-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">杨茜, 张海雄, 韩雪梅, 等. 2型糖尿病伴大血管病变患者血清高敏C反应蛋白水平变化及意义[J]. 山东医药, 2015, 55(3): 18-20.</mixed-citation></ref><ref id="hanspub.30540-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">卢薇, 王青, 李海英. 2型糖尿病患者血清胱抑素-C、超敏C反应蛋白与颈动脉内中膜厚度的相关性[J]. 重庆医学, 2014, 43(24): 3160-3162.</mixed-citation></ref><ref id="hanspub.30540-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Parlaktas, B.S., Atilgan, D., Gencten, Y., et al. (2015) A Pilot Study of the Association of Manganese Superoxide Dismutase and Glutathione Peroxidase-1 Single Gene Polymor-phisms with Prostate Cancer and Serum Prostate Specific Antigen Levels. Archives of Medical Science, 11, 994-1000.</mixed-citation></ref><ref id="hanspub.30540-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Bakacak, M., Kılınç, M., Serin, S., et al. (2015) Changes in Copper, Zinc, and Malondialdehyde Levels and Superoxide Dismutase Activities in Pre-Eclamptic Pregnancies. Medical Science Monitor, 21, 2414-2420.  
&lt;br&gt;https://doi.org/10.12659/MSM.895002</mixed-citation></ref><ref id="hanspub.30540-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">韩新生, 孙瑞灿, 张蕴, 等. 缺血性脑卒中患者颈动脉斑块性质与Cat S及Cys C的相关性[J]. 重庆医学, 2017, 46(31): 4345-4347.</mixed-citation></ref><ref id="hanspub.30540-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">陈广树, 冯烈. 2型糖尿病大血管病变与血清胱抑素C及超氧化物歧化酶的相关性研究[J]. 海南医学, 2016, 27(18): 2959-2962.</mixed-citation></ref><ref id="hanspub.30540-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">殷文静. 血清Hcy、hs-CRP及CysC与2型糖尿病患者大血管病变的关系研究[J]. 心脑血管病防治, 2016, 16(1): 16-18.</mixed-citation></ref><ref id="hanspub.30540-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">黄漓莉, 苏珂, 于健, 等. 2型糖尿病患者大血管病变与Hcy、CysC、hs-CRP的关系[J]. 广东医学, 2015, 36(10): 1518-1520.</mixed-citation></ref><ref id="hanspub.30540-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Choe, J.Y., et al. (2010) Serum Cystatin C Is a Potential En-dogenous Marker for the Estimation of Renal Function in Male Gout Patients with Renal Impairment. Journal of Korean Medical Science, 25, 42-48.  
&lt;br&gt;https://doi.org/10.3346/jkms.2010.25.1.42</mixed-citation></ref></ref-list></back></article>